Research suggests that ecological partitioning may facilitate cooperation between phages and antibiotics in treating human Pseudomonas infections. This potential synergy could lead to new clinical strategies for addressing antimicrobial resistance, including the use of bespoke phage-antibiotic combinations. The findings may offer prospects for combating refractory Pseudomonas infections, although the broader context of antimicrobial resistance remains a concern.